Neurons of the CNS and PNS differ in their response
to fibronectin (FN) and proteolytic fragments of FN. The 33 kDa C-terminal cell and heparin-binding fragment of FN, in particular, is a strong promoter of CNS neurite outgrowth. To define further the neurite-promoting activity of the 33 kDa fragment, and to investigate further the differences between PNS and CNS responses to FN and the 33 kDa fragment, we contrasted neurite outgrowth by CNS and PNS neurons on three synthetic peptides representing sequences from this fragment of FN: two heparin-binding peptides, FN-C/H I and FN-C/H II , and an integrin-binding peptide, CSl (Humphries et al., 1987) . Spinal cord (SC) neurons, from the CNS, differed from dorsal root ganglion (DRG) neurons, from the PNS, with respect to substratum preference for heparin-binding versus integrin-binding peptides. SC neurite outgrowth was greatest on the heparin-binding peptide FN-C/H II, while DRG neurite outgrowth was greatest on the a4Bl integrin-binding peptide CSl . To test whether the difference in substratum preference was due to differences in the molecular mechanism by which SC and DRG neurons interact with the 33 kDa fragment of FN, anti-/31 integrin antibodies and/or soluble heparin were added to the cultures as potential inhibitors of integrin-mediated or proteoglycan-mediated interactions with FN. SC neurite outgrowth was much more sensitive to the effect of heparin than anti-81 integrin, indicating SC neurite outgrowth may involve predominantly a heparin-sensitive mechanism. In contrast, DRG neurite outgrowth was more sensitive to anti-/31 integrin, but also affected by heparin, indicating DRG neurite outgrowth involves predominantly a fil integrin-mediated mechanism with some contribution by a heparin-sensitive mechanism.
Neurite outgrowth is a dynamic process involving interactions of the migrating neurite tip, the growth cone, with extrinsic adhesive ligands and other factors in such a manner that growing neurites follow characteristically appropriate pathways (Letoumeau, 1985 (Letoumeau, , 1989 Gunderson, 1987; Dodd and Jessell, 1988; Sanes, 1989; Reichardt and Tomaselli, 1991) . The formation of a neurite depends, in part, on interactions of cell surface molecules with extracellular matrix (ECM) components. One of the many ECM components able to provide a substratum for neurite outgrowth in vitro is fibronectin (FN) (Akers et al., 198 1; Carbonetto et al., 1983; Rogers et al., 1983 Rogers et al., , 1985 Rogers et al., , 1989 Hall et al., 1987) . FN is spatially and temporally expressed in both the developing CNS and PNS in an appropriate manner for a role in neurite outgrowth and neuronal migrations (Duband and Thiery, 1982a,b; Bronner-Fraser, 1986; Stewart and Pearlman, 1987; Chun and Shatz, 1988; Dufour et al., 1988) .
Cellular responses to FN involve multiple sequences within the FN molecule. A 75 kDa proteolytic fragment of FN containing at least two cell-binding sequences, including the arginylglycyl-asparagyl-serine (RGDS) sequence, promotes adhesion of several cell types, as well as PNS neurite outgrowth (Pierschbather and Ruoslahti, 1984; Rogers et al., 1985 Rogers et al., , 1987 McCarthy et al., 1986; Waite et al., 1987; Letourneau et al., 1988; Mugnai et al., 1988; Obara et al., 1988; Lewandowska et al., 1990) . A 33 kDa carboxy-terminal cell and heparin-binding fragment of FN differs from the 75 kDa fragment in that it strongly promotes not only PNS, but also stable CNS neurite outgrowth (Rogers et al., 1985 (Rogers et al., , 1987 . In addition, this fragment of FN promotes the RGD-independent adhesion and spreading of several other cell types (Izzard et al., 1986; McCarthy et al., 1986 McCarthy et al., , 1988 McCarthy et al., , 1990 Liao et al., 1989; Visser et al., 1989; Wayner et al., 1989; Mould et al., 1990) . A synthetic peptide approach has identified multiple sequences in the 33 kDa cell and heparinbinding fragment that promote cell adhesion and are important for cellular interactions with this region: CSl (Humphries et al., 1987 McCarthy et al., 1988 McCarthy et al., , 1990 Wayner et al., 1989; Guan and Hynes, 1990; Haugen et al., 1990; Mould et al., 1990 ), IN-C/H I (YEKPGSPPREVVPRPRPGV; McCarthy et al., 1988 McCarthy et al., , 1990 , and FN-C/H II (KNNQKSEPLIGRKKT; McCarthy et al., 1988; Haugen et al., 1990 ). IN-C/H I and FN-C/H II differ from CS 1 in that they bind heparin in solid-phase assays , and cell adhesion to these sequences is inhibited by the addition of exogenous heparin (Haugen et al., 1990; McCarthy et al., 1990) . In addition to promoting cell adhesion, the CSl sequence promotes PNS neurite outgrowth To interact with the multiple cell adhesion sequences in FN, cells make use of multiple receptors on their surfaces. One major class of cell surface receptors for FN is the /I1 integrin family, members of which bind the RGDS sequence (a5@1 integrin: Horwitz et al., 1985; Pytela et al., 1985) , the CSl sequence (a4P 1 integrin: Wayner et al., 1989; Guan and Hynes, 1990; Mould et al., 1990) , and additional unidentified sequences in FN (for review, see Buck and Horwitz, 1987; Hynes, 1987; Ruoslahti, 1988a; Yamada, 1989; Dedhar, 1990; Humphries, 1990; Reichardt and Tomaselli, 1991) . A role for pl integrins in neurite outgrowth is suggested by the expression of @l integrin on developing neurons (Bozyczko and Horwitz, 1986; Letourneau and Shattuck, 1989) . A second class of molecules that interact with matrix components, including FN, are cell surface proteoglycans (Laterra et al., 1983; Rapraeger and Bernfield, 1983; Saunders and Bemfield, 1988; LeBaron et al., 1989 ; for review, see Ruoslahti, 1988b; Reichardt and Tomaselli, 199 1) . A likely possibility is that cells interact with the heparin-binding sequences in FN using cell surface proteoglycans. Several forms of proteoglycans have been isolated from the CNS, some of which are developmentally regulated and present during periods of CNS neurite outgrowth (Margolis and Margolis, 1989; Zaremba et al., 1989; Herndon and Lander, 1990) , suggesting that proteoglycans may also play important roles in neurite outgrowth.
It is clear that CNS and PNS neurons differ with respect to their interactions with FN (Rogers et al., 1985 (Rogers et al., , 1987 . However, the molecular basis for this difference is poorly defined. Additionally, little is known of the molecular basis for neurite outgrowth on the 33 kDa carboxy-terminal cell and heparin-binding fragment of FN, which is a strong promoter of neurite outgrowth. The present study was designed to further define neuritepromoting sequences within the 33 kDa fragment of FN using the synthetic peptides named above, and to compare PNS and CNS responses to these sequences. We further investigated differences between CNS and PNS neurons using inhibitors of cell surface /3 1 integrins and heparin-like proteoglycan molecules that may mediate neurite outgrowth.
Our data demonstrate a clear difference between CNS and PNS neurons in both their FN sequence preference and in their sensitivity to these inhibitors. In general, CNS neurite outgrowth was more extensive on heparin-binding ligands, while PNS neurite outgrowth was greater on integrin-binding ligands. We propose that CNS and PNS neurons use different cell surface molecules for the adhesive interactions that mediate neurite elongation on FN.
Materials and Methods
Protein, fragment, and peptide preparation. Human plasma FN was purified as a byproduct of Factor VIII production by sequential ion exchange and gelatin affinity chromatography as described previously (McCarthy et al., 1986) . A 2 min trypsin digest followed by a cathepsin D digest produced the 75 kDa and 33166 kDa fragments as described prevrousiy (McCarthy et al., 1986 ; for location, see Fig. 1 ).
Peptides were synthesized at the University of Minnesota Microchemical Facility using a peptide synthesizer (System 990, Beckman Instruments, Fullerton, CA), using a procedure based on the Merrifield solid-phase system (Stewart and Young, 1984) as described previously Haugen et al., 1990) . Peptides were purified and their composition verified as described previously Chelberg et al., 1989; Haugen et al., 1990) . The FN peptides specifically used for this study are (for location, see Komblihtt et al., 1985) ; and CSl, with a primary sequence of DELPQLVTLPHPNLHGPEILDVPST (Humphries et al., 1987) . The sequences shown use the single letter amino acid code (K = lysine, R = arginine, H = histidine, E = glutamic acid, D = aspartic acid, Q = glutamine, N = asparagine, P = proline, G = glycine, S = serine, T = threonine, V = valine, I = isoleucine, L = leucine, Y = tyrosine).
Synthetic peptides were coupled to ovalbumin (OA), as suggested by Humphries et al. (1987) based on a procedure by Bauminger and Wilchek (1980) . Briefly, equal amounts (by weight) of peptide and ovalbumin were solubilized and mixed with a IO-fold excess (by weight) of 1 -ethyl-3-(3-dimethylaminopropyl)-carbodiimide hydrochloride (Sigma Chemical, St. Louis, MO), dissolved in water. After mixing overnight at 4°C the sample was extensively dialyzed in PBS to remove excess carbodiimide and uncoupled peptide (10,000 Da exclusion, Spectrum Medical Industries, Los Angeles, CA). The stoichiometry of peptide coupling was 2.9 mol of FN-C/H II to 1 mol of OA, with an efficiency of about 11%: 5.3 mol of FN-C/H I to 1 mol of OA. 24% efficiencv: and 6.3 mol ofCS1 to 1 mol OA, 39% efficiency, as described previously (Haugen et al., 1990) .
Cell cuhre. Dorsal root ganglia (DRG) from embryonic day 12 (E 12) or spinal cords (SC) from E8 White Leghorn chicks were dissected, and the cells dissociated by a 20 min incubation in 0.25% trypsin followed by gentle trituration. Cells were washed twice in 10% serum medium, and then cultured in serum-free defined media in 96 well Immulon-1 plates that had been coated overnight with the appropriate substratum. Serum-free (defined) medium was composed of-F14 (GIBCO, Grand Island, NY) buffered with bicarbonate, to which the following were added: insulin (5 pg/ml), phosphocreatine (5 mM Neurite assays. Substrata were prepared by adsorbing FN, proteolytic fragments of FN, and synthetic peptides, which had been diluted to the appropriate concentrations in Voller's carbonate buffer, to Immulon-1 plates, and, subsequently, nonspecific sites were blocked by addition of a solution of 5 mg/ml of bovine serum albumin (BSA, fatty acid free, Miles. Nanerville. IL) in Dulbecco's nhosohate-buffered saline (DPBS) for 2-3 hi as described previously (Haugen et al., 1990) . Prior to the addition ofcells, the substrata were rinsed three times with DPBS. Chick DRG or SC neurons were resuspended at 40,000 cells/ml (DRGs) or 60,000 cells/ml (SC), and 100 ~1 were added to each well. Cells were allowed to extend neurites for 24 hr at 37°C in 5% CO,. Adherent cells were fixed with 2% glutaraldehyde for 20-40 min and counted using phase-contrast microscopy with a 10 x objective on a Nikon inverted scope. Cells observed in one diameter across each well, 3.5 fields of view (approximately 20% of the total area of each well), were counted. Neurons were identified according to morphology as having round, phase-bright cell bodies, and scored as having neurites if there was at least one process greater than the cell diameter.
Inhibition assays. Substrata and cells were prepared as described above.
For peptide or antibody inhibition assays, cells were cultured for 24 hr on the appropriate substrata in media containing either the indicated concentration of soluble peptide or 20 &ml of purified W lBl0 IgG, which recognizes the chicken pl integrin subunit (a generous gift of Dr. A. Horwitz, University of Illinois, Champaign-Urbana), respectively. For heparin inhibition assays, the substratum was preincubated for 1 hr with 10 @/ml soluble heparin (Sigma Chemical Co., St. Louis, MO) at 37"C, after which time the nonbound heparin was removed by three rinses in PBS. Cells were then added to the substratum, pretreated with heparin, and cultured for 24 hr in defined medium or delined medium plus W lBl0 antibody (for additive heparin + antibody inhibition experiments). In all cases, neurite outgrowth was assayed by counting fixed cells, as described above.
Results

PNS and CNS neurite outgrowth d@ers in substratum preference
Previous studies suggested that central and peripheral neurons differ in their responses to FN (Rogers et al., 1983 (Rogers et al., , 1985 (Rogers et al., , 1987 . To investigate further such differences, sensory DRG neurons from the PNS and SC neurons from the CNS were dissociated and cultured on FN-derived substrata to compare their responses. Substrata were treated with equimolar concentrations of FN or two tryptic fragments of FN: a 75 kDa fragment containing the RGDS sequence, or a mixture of the 33 kDa and 66 kDa fragments derived from the C-terminal heparin-binding region of FN A-chains and B-chains, respectively (Fig. 1) . DRG and SC neurons differed in their responses to these three substrata. DRG neurite outgrowth was greatest on the 75 kDa fragment, while SC neurite outgrowth was greatest on the 33/66 kDa fragments (Fig. 2) . Substrata treated with either FN or the 75 kDa fragment were more effective at promoting DRG neurite outgrowth than SC neurite outgrowth (Fig. 2) . In contrast, substrata treated with the 33/66 kDa heparin-binding fragments were more effective at promoting SC neurite outgrowth than DRG neurite outgrowth (Fig. 2) . Using a soluble RGD-containing peptide, we determined, as expected from previous work (Rogers et al., 1987) that neurite outgrowth on the 75 kDa fragment was totally RGD dependent (not shown). In these cultures, few non-neuronal cells were present, and neurites extended directly on the substratum, rather than on the surfaces of non-neuronal cells (Fig. 3) .
In order to further define neurite-promoting sequences in the 33/66 kDa cell and heparin-binding fragments of FN, we tested three synthetic peptides whose sequences are found in this region of FN for their neurite-promoting ability. Each peptide has been shown to support cell-substratum adhesion (for location in the EN sequence, see Fig. 1 ): EN-C/H I ) FN-C/H II Haugen et al., 1990) and CSl (Humphries et al., 1987 Wayner et al., 1989; Haugen et al., 1990; McCarthy et al., 1990 ). FN-C/H I and EN-C/H II both bind heparin, while CSl does not . FN-C/H I and FN-C/H II are present in all isoforms of FN, while CSl is located within the alternatively spliced 111~s region unique to FN A-chains. In order to facilitate binding to the substratum, all peptides were conjugated to OA (Haugen et al., 1990) .
Both SC and DRG neurons extended neurites on all three peptides in a concentration-dependent manner, but differed in their responses to low concentrations of each peptide. The minimum concentration of FYI-C/H II-OA that induced SC neurite outgrowth was one-fifth of the minimum concentration required for DRG neurite outgrowth (Fig. 4A) . Additionally, the maximum level of neurite outgrowth observed on FN-C/H II-OA was greater for SC neurons than for DRG neurons. In contrast, DRG neurons responded to significantly lower concentrations of CS l-OA than did SC neurons (Fig. 4B) . Finally, SC and DRG neurite outgrowth on EN-C/H I-OA was similar at all concentrations (Fig. 4c) . When the data from the different substrata were compared directly, neurite outgrowth by SC neurons was greatest on FYI-C/H II-OA, while neurite outgrowth by DRG neurons was greatest on CS l-OA (not shown), indicating clear differences in substratum preference.
As an additional means to assess the relative role of each peptide in DRG and SC neurite outgrowth, the peptides were each added in solution as potential inhibitors that might compete with neurite outgrowth on the 33/66 kDa fragments. DRG neurite outgrowth on the 33/66 kDa fragments was inhibited to the greatest extent by soluble CSl, less effectively by soluble FN-C/H I, and least effectively by soluble FN-C/H II (Fig. 5A) . In contrast, SC neurite outgrowth on the 33166 kDa fragments was significantly inhibited by soluble EN-C/H II, less effectively inhibited by soluble FN-C/H I, and virtually unaffected by soluble CSl (Fig. 5B ). These results parallel the different substratum preferences of DRG and SC neurons noted in Figure 4 , suggesting that the differences in substratum preference between DRG and SC neurons relate to differences in their interactions with these peptide sequences within the 33/66 kDa fragments.
Soluble heparin and anti-p1 integrin antibodies have deferent effects on CNS and PNS neurite outgrowth
The preceding experiments demonstrate that DRG and SC neurons prefer to interact with different regions of the FN molecule, C-terminal cell and heparin-binding region, substrata were pretreated with exogenous heparin as a potential competitive blocker of a cell surface heparin-like proteoglycan that may mediate neuron-to-substratum adhesion and neurite outgrowth. For both SC and DRG neurons, pretreatment of the substratum with heparin most effectively inhibited neurite outgrowth on FN-C/H II-OA treated substrata (Fig. 6) , consistent with previous results that cell adhesion to FN-C/H II is heparin sensitive (Haugen et al., 1990) . Heparin also inhibited neurite outgrowth on the other heparin-binding peptide, FN-C/H I-OA. Inhibition by heparin on FN-C/H I-OA was partial for DRG neurite outgrowth and virtually complete for SC neurite outgrowth (Fig.  6) . Heparin had little effect on neurite outgrowth on CSl-OA. In all cases, SC neurons were more sensitive to the effects of heparin than were DRG neurons. SC neurite outgrowth was inhibited by heparin on substrata treated with the 33/66 kDa fragments or intact FN. In contrast, DRG neurite outgrowth was unaffected by heparin on both of these substrata (Fig. 6) . The sensitivity of neurite outgrowth to heparin was specific, since chondroitin sulfate had virtually no effect on either SC or DRG neurite outgrowth on these substrata (not shown; see Haugen et al., 1990) . Considering that intact FN and the 33/66 kDa fragments have multiple sites for cell interaction, these results suggest SC neurite outgrowth is more dependent than DRG neurite outgrowth on the sites within FN and the 33/66 kDa fragments that bind heparin.
As another approach to define the cell surface molecules involved in DRG and SC neurite outgrowth, an antibody that recognizes and blocks the chicken p 1 integrin subunit, W 1 B 10, was added to the cultures (Dr. A. Horwitz, University of Illinois). W 1 B 10 antibody most effectively inhibited DRG neurite outgrowth on CSl-OA (Fig. 7) , which binds the a4fil integrin on hematopoietic cell surfaces (Wayner et al., 1989; Guan and Hynes, 1990; Mould et al., 1990) . In contrast, SC neurite outgrowth on CS I-OA was only partially affected by the W 1 B 10 antibody (Fig. 7) . W 1 B 10 was least effective on substrata treated with the heparin-binding peptide FN-C/H II-OA (Fig. 7) . W 1 B 10 also had no effect on SC neurite outgrowth on substrata treated with the other heparin-binding peptide, FN-C/H I-OA. However, DRG neurite outgrowth on FN-C/H I-OA was partially inhibited by the W 1 B 10 antibody, suggesting that DRG neurons use an integrin component to interact with the FN-C/H I sequence.
In sharp contrast to inhibition by heparin, W 1 B 10 was more inhibitory for DRG neurite outgrowth than for SC neurite outgrowth on all substrata. DRG neurite outgrowth was partially inhibited by W lBl0 antibody on the 33/66 kDa fragments, which contain the CS 1 sequence, and FN, which contains multiple 61 integrin-binding sites (Fig. 7) . SC neurite outgrowth on these substrata was affected by the W 1 B 10 antibody to a lesser extent than was DRG neurite outgrowth. The difference between SC and DRG sensitivity to W 1 B 10 antibody was also notable on substrata treated with CS l-OA or FN-C/H I-OA. These data suggest that DRG neurons rely more on pl integrin-mediated mechanisms for neurite outgrowth than do SC neurons. Since both heparin-sensitive and @l integrin-mediated mechanisms play a role in neurite outgrowth in response to the C-terminal heparin-binding region of FN, we determined whether these mechanisms might be synergistic by adding both heparin and W 1 B 10 antibodies to the neuronal cultures. For DRG neurite outgrowth on FN-C/H II-OA treated substrata, heparin alone was just as inhibitory as WlBlO and heparin added together (Fig. 8A) , suggesting a simple interaction of a cell surface heparin-like proteoglycan with this sequence. In contrast, the addition of both heparin and W 1 B 10 synergistically eliminated DRG neurite outgrowth on FN-C/H I-OA, while either one alone had only a partial effect on DRG neurite outgrowth (Fig.  8A) . These results suggest DRG neurite outgrowth on FN-C/H I is mediated by both heparin-sensitive and pl integrin-mediated mechanisms. Inhibition of DRG neurite outgrowth on CS l-OA and the 33/66 kDa fragments by both heparin and W 1 B 10 was not additive in any significant manner (Fig. 6A) , indicating that DRG neurons interact with the CSl sequence and the 331 66 kDa C-terminal heparin-binding fragments using predominantly a fi 1 integrin-mediated mechanism. As was noted for DRG neurite outgrowth, SC neurite outgrowth on FN-C/H II-OA can be totally accounted for by a heparin-sensitive mechanism (Fig. 8B) . In sharp contrast to DRG neurite outgrowth, the inhibition of SC neurite outgrowth on FN-C/H I-OA by heparin and anti-@1 integrins was not additive, since heparin alone had the greatest effect on SC neurite outgrowth (Fig. 8B) . Also in contrast to DRG neurite outgrowth, SC neurite outgrowth on a 33/66 kDa treated substratum was not inhibited by W 1 B 10 antibody, but was effectively inhibited by heparin alone (Fig. 8B) , indicating that SC neurons rely predominantly on heparin-sensitive mechanisms for neurite outgrowth on the 33/66 kDa heparin-binding fragments. 
Discussion
The purpose of the present study was to investigate the molecular basis for differences in central and peripheral neuronal responses to the FN C-terminal cell and heparin-binding fragment. In this study, we demonstrate clear differences in CNS and PNS neurite outgrowth with respect to preference for polypeptide sequences from this region of FN as substrata on which to extend neurites. In general, SC neurons preferred heparin-binding substrata such as the 33166 kDa fragments of FN and the peptide FN-C/H II, while DRG neurons preferred integrin-binding substrata such as the 75 kDa FN fragment and the peptide CSl. CNS and PNS neurons also differed in that SC neurons were more sensitive to inhibition by soluble heparin, while DRG neurons were more affected by anti-p 1 integrin antibodies. We propose that CNS and PNS neurons differ in their use of cell surface molecules when extending neurites in response to FN.
This study also indicates that neurons use multiple sequences within the C-terminal cell and heparin-binding fragment of FN to extend neurites. Both SC and DRG neurons extended neurites on FN-C/H II, FN-C/H I, and CS 1. Further, with the exception of soluble CS 1 in SC cultures, each of these peptides in solution partially inhibited neurite outgrowth on the 33166 kDa fragment, indicating that neurons interact directly with these sequences within the context of the larger 33/66 kDa fragments. FN-C/H II was an especially effective substratum for neurite outgrowth. These and previous results identifying FN-C/H II as a promoter of neuroblastoma adhesion and spreading (Haugen et al., 1990) suggest that IN-C/H II is an important neural cell recognition sequence within FN. Second, our results identify IN-C/H I as a neurite-promoting sequence. FN-C/H I has also been shown to promote melanoma adhesion and spreading indicating an important role for this sequence in cellular responses to FN by a variety of cell types. Finally, CS 1 was also a neurite-promoting sequence, confirming the results of Humphries et al. (1988) for DRG neurons. The observation that neurons use three independent sequences for neurite outgrowth is consistent with a growing body of evidence suggesting that cellular interactions with FN and the C-terminal cell and heparin-binding fragment involve multiple sites (McCarthy et al., 1986 Humphries et al., 1987 Humphries et al., , 1988 Mugnai et al., 1988; Obara et al., 1988; Haugen et al., 1990; Lewandowska et al., 1990) .
While both SC and DRG neurons extended neurites on the three peptides tested, they differed in the effectiveness of their response to low concentrations of each of these peptides. For example, SC neurons responded to concentrations of FN-C/H II nearly an order of magnitude lower than those required to elicit the same DRG response. In contrast, DRG neurons responded to much lower concentrations of CSl than did SC neurons. Further, SC neurons were most inhibited by soluble FN-C/H II, while DRG neurons were most inhibited by soluble CS 1. Such differences in SC and DRG sensitivity to different sequences suggest there may be differences between DRG and SC neurons at the receptor level. One possibility is that DRG and SC neurons differ in the expression of particular cell surface receptors that interact with the FN-C/H II and the CSl sequences.
One way in which SC and DRG neurons may differ is with respect to their use of the integrin receptors for FN. Our data suggest that DRG neurons rely extensively on @l integrins for their interactions with FN and the 33/66 kDa fragments. DRG neurons preferred integrin-binding substrata and were more affected by the addition of anti-p1 integrin antibodies than by heparin. Additionally, anti-p1 integrin antibodies effectively inhibited DRG neurite outgrowth on the 33/66 kDa fragments. The behavior of SC neurons was in sharp contrast to that of DRG neurons. SC neurons extended neurites on the a4pl integrin-binding ligand, CS 1, but much less effectively than DRG neurons. Additionally, unlike DRG neurite outgrowth, SC neurite outgrowth on the 33166 kDa fragments was unaffected by soluble CSl. Further, SC neurite outgrowth was inhibited by the anti-/31 integrin antibody to a much lesser extent than was DRG neurite outgrowth. One possible explanation for these differences is that SC and DRG neurons differ quantitatively in expression of p I integrin complexes. Support for this idea comes from immunofluorescence studies with anti-p1 integrin antibodies, in which SC staining was less intense than DRG staining (Letourneau et al., 1988 , using a polyclonal antibody that recognizes the chicken p 1 integrin; P. C. Letoumeau, unpublished observations using W 1 B 10 antibody). Alternatively, the relative inability of the W 1 B 10 antibody to inhibit SC neurite outgrowth may suggest that SC neurons interact with the integrin-binding sequences in FN, such as CS 1, using a P-subunit different from pl (Holzmann et al., 1989) . A further possibility is that there are differences between SC and DRG p 1 integrins in activation or conformation that affect ligand binding, such as those noted by Neugebauer and Reichardt (199 1) .
SC and DRG neurons may also rely on a second class of receptors, cell surface proteoglycans, for neurite outgrowth on FN. Cell surface proteoglycans are implicated by several studies as mediators of cell-matrix interactions (Laterra et al., 1983; Rapraeger and Bemfield, 1983; Woods et al., 1985; Mugnai et al., 1988; Saunders and Bernfield, 1988; Culp, 1989; LeBaron et al., 1989) . Our findings that SC neurons prefer heparin-binding sequences in FN and that SC neurite outgrowth is extremely sensitive to inhibition by heparin suggest SC neurons are more dependent on cell surface heparin-like proteoglycan molecules than on integrins for interactions with FN. A role for a cell surface proteoglycan in SC neurite outgrowth is further supported by the observations that only heparin, and not anti-p1 integrin antibodies, affected SC neurite outgrowth on the 33166 kDa fragments. DRG neurons may also make use of a cell surface heparin-like proteoglycan, since they extended neurites on the heparin-binding peptides FN-C/H II and IN-C/H I and since DRG neurite outgrowth was partially affected by exogenous heparin. However, DRG neurite outgrowth on IN-C/H I was inhibited by heparin to a lesser extent than was SC neurite outgrowth. Cell surface proteoglycans are likely to play an important role in neurite outgrowth, especially in the CNS.
DRG neurite outgrowth on IN-C/H I may involve both a p 1 integrin and a cell surface proteoglycan. DRG neurite outgrowth on this peptide was sensitive to heparin, consistent with the described heparin-binding properties of IN-C/H I , but was also sensitive to anti-81 integrin antibodies. Treatment with both heparin and anti-P1 integrin antibodies totally eliminated DRG neurite outgrowth on FN-C/H I, indicating that DRG neurite outgrowth relies on integrinmediated and heparin-sensitive mechanisms in an additive or synergistic manner. Neugebauer et al. (1988) and have also noted that neurons make use of other types of cell surface molecules in concert with integrins when extending neurites on various substrata.
The results presented here suggest that neurons interact with multiple sites in the FN molecule using both integrin and heparin-like proteoglycan receptors on their surfaces. Cell-specific differences at the receptor level could have profound effects on how a cell interacts with complex molecules that contain multiple sites, such as FN, and could explain the differences noted between SC and DRG neurons. It is not yet known exactly how the differences between CNS and PNS neurite outgrowth on these FN sequences are involved in neuronal development, but it is likely these cell-specific differences have important consequences for the complex and diverse developmental events in the CNS and PNS.
